US Branded Generics Market to Reach $172.03 Million by 2027 from $77.9 Million in 2022 - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Branded Generics Market Research Report by Product (Trade Named Generics and Value-Added), Application, Distribution Channel, State - United States Forecast to 2027 - Cumulative Impact of COVID-19" report has been added to ResearchAndMarkets.com's offering.

The United States Branded Generics Market size was estimated at USD 64.00 million in 2021, USD 77.90 million in 2022, and is projected to grow at a Compound Annual Growth Rate (CAGR) of 17.91% to reach USD 172.03 million by 2027.

Market Statistics:

The report provides market sizing and forecast across seven major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF. It helps organization leaders make better decisions when currency exchange data is readily available. In this report, the years 2019 and 2020 are considered historical years, 2021 as the base year, 2022 as the estimated year, and years from 2023 to 2027 are considered the forecast period.

Market Segmentation & Coverage:

This research report categorizes the Branded Generics to forecast the revenues and analyze the trends in each of the following sub-markets:

• Based on Product, the market was studied across Trade Named Generics and Value-Added.
• Based on Application, the market was studied across Anti-Cancer, Anti-Infective, Cardiovascular, and CNS.
• Based on Distribution Channel, the market was studied across Clinics, Hospital Pharmacy, and Pharmacy.
• Based on State, the market was studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas.

Key Topics Covered:

1. Preface

1.1. Objectives of the Study

1.2. Market Segmentation & Coverage

1.3. Years Considered for the Study

1.4. Currency & Pricing

1.5. Language

1.6. Limitations

1.7. Assumptions

1.8. Stakeholders

2. Research Methodology

2.1. Define: Research Objective

2.2. Determine: Research Design

2.3. Prepare: Research Instrument

2.4. Collect: Data Source

2.5. Analyze: Data Interpretation

2.6. Formulate: Data Verification

2.7. Publish: Research Report

2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

5.1. Market Dynamics

5.1.1. Drivers

5.1.2. Restraints

5.1.3. Opportunities

5.1.4. Challenges

5.2. Cumulative Impact of COVID-19

6. Branded Generics Market, by Product

6.1. Introduction

6.2. Trade Named Generics

6.3. Value-Added

7. Branded Generics Market, by Application

7.1. Introduction

7.2. Anti-Cancer

7.3. Anti-Infective

7.4. Cardiovascular

7.5. CNS

8. Branded Generics Market, by Distribution Channel

8.1. Introduction

8.2. Clinics

8.3. Hospital Pharmacy

8.4. Pharmacy

9. California Branded Generics Market

10. Florida Branded Generics Market

11. Illinois Branded Generics Market

12. New York Branded Generics Market

13. Ohio Branded Generics Market

14. Pennsylvania Branded Generics Market

15. Texas Branded Generics Market

16. Competitive Landscape

16.1. FPNV Positioning Matrix

16.1.1. Quadrants

16.1.2. Business Strategy

16.1.3. Product Satisfaction

16.2. Market Ranking Analysis

16.3. Market Share Analysis, By Key Player

16.4. Competitive Scenario

16.4.1. Merger & Acquisition

16.4.2. Agreement, Collaboration, & Partnership

16.4.3. New Product Launch & Enhancement

16.4.4. Investment & Funding

16.4.5. Award, Recognition, & Expansion

Companies Mentioned

• Amneal Pharmaceuticals
• Apotex Inc.
• AstraZeneca PLC
• Aurobindo Pharma Limited
• Bausch Health Companies Inc
• Cadila Healthcare Limited
• Cipla Inc
• Dr. Reddy's Laboratories Ltd.
• Endo International PLC
• Eris Lifesciences Limited
• Eva Pharma
• Fresenius Kabi
• GlaxoSmithKline PLC
• Glenmark Pharmaceuticals Limited
• Hetero Drugs Limited
• Lupin Pharmaceuticals, Inc.
• Mylan N.V.
• Novartis International AG
• Pfizer Inc
• Sandoz International GmbH
• Sanofi S.A.
• STADA Arzneimittel AG
• Strides Arcolab Ltd
• Sun Pharmaceutical Industries Ltd
• Teva Pharmaceutical Industries Ltd
• Torrent Pharmaceuticals Ltd

For more information about this report visit https://www.researchandmarkets.com/r/ch3blj

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com

For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900